• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of jcinvestThe Journal of Clinical InvestigationCurrent IssueArchiveSubscriptionAbout the Journal
J Clin Invest. Apr 15, 1996; 97(8): 1942–1951.
PMCID: PMC507264

The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes.


Urokinase receptors (uPAR; CD87) from complexes with complement receptor 3 (CR3) (CD11b/CD18), a beta2 integrin. In this study, we sought to determine if this association modulates the adhesive function of CR3. Both CR3 and uPAR concentrate at the ventral surface of fibrinogen-adherent human monocytes, and CR3-uPAR coupling increases substantially upon adhesion to fibrinogen. Pretreatment with anti-uPAR monoclonal antibody reduced adhesion to CR3 counterligands (fibrinogen and keyhole limpet hemocyanin) by 50%, but did not affect adhesion to fibronectin, a beta1 integrin counterligand. Antisense (AS) oligonucleotides were used to determine if selectively suppressing uPAR expression also modulates CR3 adhesive function. AS-uPAR oligo reduced CR3-dependent adhesion by 43+/-9% (P<0.01), but did not affect CR3-independent adhesion. To determine if the effects of uPAR are mediated through its ligand, monocytes were pre-treated with AS oligo to block uPA expression. Unlike the effects of blocking uPAR expression, AS-uPA oligo increased adhesion by 46% (P<0.005), and exogenous intact uPA, but not uPA fragments, reversed this effect. We conclude that complex formation with uPAR facilitates the adhesive functions of CR3. This function of uPAR is not dependent upon its occupancy with uPA, which negatively influences adhesion.

Full Text

The Full Text of this article is available as a PDF (474K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Beekhuizen H, van Furth R. Monocyte adherence to human vascular endothelium. J Leukoc Biol. 1993 Oct;54(4):363–378. [PubMed]
  • Detmers PA, Wright SD, Olsen E, Kimball B, Cohn ZA. Aggregation of complement receptors on human neutrophils in the absence of ligand. J Cell Biol. 1987 Sep;105(3):1137–1145. [PMC free article] [PubMed]
  • Hermanowski-Vosatka A, Detmers PA, Götze O, Silverstein SC, Wright SD. Clustering of ligand on the surface of a particle enhances adhesion to receptor-bearing cells. J Biol Chem. 1988 Nov 25;263(33):17822–17827. [PubMed]
  • Wright SD, Ramos RA, Hermanowski-Vosatka A, Rockwell P, Detmers PA. Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: dependence on lipopolysaccharide binding protein and CD14. J Exp Med. 1991 May 1;173(5):1281–1286. [PMC free article] [PubMed]
  • Detmers PA, Lo SK, Olsen-Egbert E, Walz A, Baggiolini M, Cohn ZA. Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med. 1990 Apr 1;171(4):1155–1162. [PMC free article] [PubMed]
  • Diamond MS, Springer TA. A subpopulation of Mac-1 (CD11b/CD18) molecules mediates neutrophil adhesion to ICAM-1 and fibrinogen. J Cell Biol. 1993 Jan;120(2):545–556. [PMC free article] [PubMed]
  • Buyon JP, Slade SG, Reibman J, Abramson SB, Philips MR, Weissmann G, Winchester R. Constitutive and induced phosphorylation of the alpha- and beta-chains of the CD11/CD18 leukocyte integrin family. Relationship to adhesion-dependent functions. J Immunol. 1990 Jan 1;144(1):191–197. [PubMed]
  • Chatila TA, Geha RS, Arnaout MA. Constitutive and stimulus-induced phosphorylation of CD11/CD18 leukocyte adhesion molecules. J Cell Biol. 1989 Dec;109(6 Pt 2):3435–3444. [PMC free article] [PubMed]
  • Altieri DC. Occupancy of CD11b/CD18 (Mac-1) divalent ion binding site(s) induces leukocyte adhesion. J Immunol. 1991 Sep 15;147(6):1891–1898. [PubMed]
  • Hermanowski-Vosatka A, Van Strijp JA, Swiggard WJ, Wright SD. Integrin modulating factor-1: a lipid that alters the function of leukocyte integrins. Cell. 1992 Jan 24;68(2):341–352. [PubMed]
  • Zhou M, Todd RF, 3rd, van de Winkel JG, Petty HR. Cocapping of the leukoadhesin molecules complement receptor type 3 and lymphocyte function-associated antigen-1 with Fc gamma receptor III on human neutrophils. Possible role of lectin-like interactions. J Immunol. 1993 Apr 1;150(7):3030–3041. [PubMed]
  • Sehgal G, Zhang K, Todd RF, 3rd, Boxer LA, Petty HR. Lectin-like inhibition of immune complex receptor-mediated stimulation of neutrophils. Effects on cytosolic calcium release and superoxide production. J Immunol. 1993 May 15;150(10):4571–4580. [PubMed]
  • Bohuslav J, Horejsí V, Hansmann C, Stöckl J, Weidle UH, Majdic O, Bartke I, Knapp W, Stockinger H. Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes. J Exp Med. 1995 Apr 1;181(4):1381–1390. [PMC free article] [PubMed]
  • Petty HR, Todd RF., 3rd Receptor-receptor interactions of complement receptor type 3 in neutrophil membranes. J Leukoc Biol. 1993 Nov;54(5):492–494. [PubMed]
  • Xue W, Kindzelskii AL, Todd RF, 3rd, Petty HR. Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membranes. J Immunol. 1994 May 1;152(9):4630–4640. [PubMed]
  • Detmers PA, Zhou D, Powell DE. Different signaling pathways for CD18-mediated adhesion and Fc-mediated phagocytosis. Response of neutrophils to LPS. J Immunol. 1994 Sep 1;153(5):2137–2145. [PubMed]
  • Krauss JC, PooH, Xue W, Mayo-Bond L, Todd RF, 3rd, Petty HR. Reconstitution of antibody-dependent phagocytosis in fibroblasts expressing Fc gamma receptor IIIB and the complement receptor type 3. J Immunol. 1994 Aug 15;153(4):1769–1777. [PubMed]
  • Cao D, Mizukami IF, Garni-Wagner BA, Kindzelskii AL, Todd RF, 3rd, Boxer LA, Petty HR. Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release. Possible roles of complement receptor type 3 and calcium. J Immunol. 1995 Feb 15;154(4):1817–1829. [PubMed]
  • Gyetko MR, Todd RF, 3rd, Wilkinson CC, Sitrin RG. The urokinase receptor is required for human monocyte chemotaxis in vitro. J Clin Invest. 1994 Apr;93(4):1380–1387. [PMC free article] [PubMed]
  • Kirchheimer JC, Remold HG. Endogenous receptor-bound urokinase mediates tissue invasion of human monocytes. J Immunol. 1989 Oct 15;143(8):2634–2639. [PubMed]
  • Min HY, Semnani R, Mizukami IF, Watt K, Todd RF, 3rd, Liu DY. cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator. J Immunol. 1992 Jun 1;148(11):3636–3642. [PubMed]
  • Mizukami IF, Garni-Wagner BA, DeAngelo LM, Liebert M, Flint A, Lawrence DA, Cohen RL, Todd RF., 3rd Immunologic detection of the cellular receptor for urokinase plasminogen activator. Clin Immunol Immunopathol. 1994 Apr;71(1):96–104. [PubMed]
  • Dana N, Styrt B, Griffin JD, Todd RF, 3rd, Klempner MS, Arnaout MA. Two functional domains in the phagocyte membrane glycoprotein Mo1 identified with monoclonal antibodies. J Immunol. 1986 Nov 15;137(10):3259–3263. [PubMed]
  • Sanchez-Madrid F, Nagy JA, Robbins E, Simon P, Springer TA. A human leukocyte differentiation antigen family with distinct alpha-subunits and a common beta-subunit: the lymphocyte function-associated antigen (LFA-1), the C3bi complement receptor (OKM1/Mac-1), and the p150,95 molecule. J Exp Med. 1983 Dec 1;158(6):1785–1803. [PMC free article] [PubMed]
  • Vissers MC, Jester SA, Fantone JC. Rapid purification of human peripheral blood monocytes by centrifugation through Ficoll-Hypaque and Sepracell-MN. J Immunol Methods. 1988 Jun 13;110(2):203–207. [PubMed]
  • Uster PS, Pagano RE. Resonance energy transfer microscopy: observations of membrane-bound fluorescent probes in model membranes and in living cells. J Cell Biol. 1986 Oct;103(4):1221–1234. [PMC free article] [PubMed]
  • Zhou MJ, Todd RF, 3rd, Petty HR. Detection of transmembrane linkages between immunoglobulin or complement receptors and the neutrophil's cortical microfilaments by resonance energy transfer microscopy. J Mol Biol. 1991 Mar 20;218(2):263–268. [PubMed]
  • Zhou MJ, Poo H, Todd RF, 3rd, Petty HR. Surface-bound immune complexes trigger transmembrane proximity between complement receptor type 3 and the neutrophil's cortical microfilaments. J Immunol. 1992 Jun 1;148(11):3550–3553. [PubMed]
  • Maher RJ, Cao D, Boxer LA, Petty HR. Simultaneous calcium-dependent delivery of neutrophil lactoferrin and reactive oxygen metabolites to erythrocyte targets: evidence supporting granule-dependent triggering of superoxide deposition. J Cell Physiol. 1993 Aug;156(2):226–234. [PubMed]
  • Shappell SB, Toman C, Anderson DC, Taylor AA, Entman ML, Smith CW. Mac-1 (CD11b/CD18) mediates adherence-dependent hydrogen peroxide production by human and canine neutrophils. J Immunol. 1990 Apr 1;144(7):2702–2711. [PubMed]
  • Suchard SJ, Burton MJ, Dixit VM, Boxer LA. Human neutrophil adherence to thrombospondin occurs through a CD11/CD18-independent mechanism. J Immunol. 1991 Jun 1;146(11):3945–3952. [PubMed]
  • Riccio A, Grimaldi G, Verde P, Sebastio G, Boast S, Blasi F. The human urokinase-plasminogen activator gene and its promoter. Nucleic Acids Res. 1985 Apr 25;13(8):2759–2771. [PMC free article] [PubMed]
  • Roldan AL, Cubellis MV, Masucci MT, Behrendt N, Lund LR, Danø K, Appella E, Blasi F. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J. 1990 Feb;9(2):467–474. [PMC free article] [PubMed]
  • Wright SD, Weitz JI, Huang AJ, Levin SM, Silverstein SC, Loike JD. Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen. Proc Natl Acad Sci U S A. 1988 Oct;85(20):7734–7738. [PMC free article] [PubMed]
  • Myones BL, Dalzell JG, Hogg N, Ross GD. Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3. J Clin Invest. 1988 Aug;82(2):640–651. [PMC free article] [PubMed]
  • Watson PH, Pon RT, Shiu RP. Inhibition of cell adhesion to plastic substratum by phosphorothioate oligonucleotide. Exp Cell Res. 1992 Oct;202(2):391–397. [PubMed]
  • Remold-O'Donnell E, Lewandrowski K. Macrophage surface component gp160: sensitivity to plasmin and other proteases. J Immunol. 1982 Apr;128(4):1541–1544. [PubMed]
  • Albelda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J. 1994 May;8(8):504–512. [PubMed]
  • Gyetko MR, Sitrin RG, Fuller JA, Todd RF, 3rd, Petty H, Standiford TJ. Function of the urokinase receptor (CD87) in neutrophil chemotaxis. J Leukoc Biol. 1995 Nov;58(5):533–538. [PubMed]
  • Szöllösi J, Damjanovich S, Mulhern SA, Trón L. Fluorescence energy transfer and membrane potential measurements monitor dynamic properties of cell membranes: a critical review. Prog Biophys Mol Biol. 1987;49(2-3):65–87. [PubMed]
  • Graham IL, Gresham HD, Brown EJ. An immobile subset of plasma membrane CD11b/CD18 (Mac-1) is involved in phagocytosis of targets recognized by multiple receptors. J Immunol. 1989 Apr 1;142(7):2352–2358. [PubMed]
  • Pavalko FM, LaRoche SM. Activation of human neutrophils induces an interaction between the integrin beta 2-subunit (CD18) and the actin binding protein alpha-actinin. J Immunol. 1993 Oct 1;151(7):3795–3807. [PubMed]
  • Ciambrone GJ, McKeown-Longo PJ. Vitronectin regulates the synthesis and localization of urokinase-type plasminogen activator in HT-1080 cells. J Biol Chem. 1992 Jul 5;267(19):13617–13622. [PubMed]
  • Takahashi K, Ikeo K, Gojobori T, Tanifuji M. Local function of urokinase receptor at the adhesion contact sites of a metastatic tumor cell. Thromb Res Suppl. 1990;10:55–61. [PubMed]
  • Kindzelskii AL, Xue W, Todd RF, 3rd, Boxer LA, Petty HR. Aberrant capping of membrane proteins on neutrophils from patients with leukocyte adhesion deficiency. Blood. 1994 Mar 15;83(6):1650–1655. [PubMed]
  • Francis JW, Todd RF, 3rd, Boxer LA, Petty HR. Sequential expression of cell surface C3bi receptors during neutrophil locomotion. J Cell Physiol. 1989 Sep;140(3):519–523. [PubMed]
  • Wei Y, Waltz DA, Rao N, Drummond RJ, Rosenberg S, Chapman HA. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J Biol Chem. 1994 Dec 23;269(51):32380–32388. [PubMed]
  • Loike JD, Sodeik B, Cao L, Leucona S, Weitz JI, Detmers PA, Wright SD, Silverstein SC. CD11c/CD18 on neutrophils recognizes a domain at the N terminus of the A alpha chain of fibrinogen. Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):1044–1048. [PMC free article] [PubMed]
  • Vassalli JD, Wohlwend A, Belin D. Urokinase-catalyzed plasminogen activation at the monocyte/macrophage cell surface: a localized and regulated proteolytic system. Curr Top Microbiol Immunol. 1992;181:65–86. [PubMed]
  • Picone R, Kajtaniak EL, Nielsen LS, Behrendt N, Mastronicola MR, Cubellis MV, Stoppelli MP, Pedersen S, Danø K, Blasi F. Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate. J Cell Biol. 1989 Feb;108(2):693–702. [PMC free article] [PubMed]
  • Olson D, Pöllänen J, Høyer-Hansen G, Rønne E, Sakaguchi K, Wun TC, Appella E, Danø K, Blasi F. Internalization of the urokinase-plasminogen activator inhibitor type-1 complex is mediated by the urokinase receptor. J Biol Chem. 1992 May 5;267(13):9129–9133. [PubMed]
  • Cubellis MV, Wun TC, Blasi F. Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI-1. EMBO J. 1990 Apr;9(4):1079–1085. [PMC free article] [PubMed]
  • Chapman HA, Jr, Stone OL, Vavrin Z. Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation. J Clin Invest. 1984 Mar;73(3):806–815. [PMC free article] [PubMed]
  • Mochan E, Keler T. Plasmin degradation of cartilage proteoglycan. Biochim Biophys Acta. 1984 Aug 21;800(3):312–315. [PubMed]
  • Murphy G, Docherty AJ. The matrix metalloproteinases and their inhibitors. Am J Respir Cell Mol Biol. 1992 Aug;7(2):120–125. [PubMed]
  • Carlos TM, Dobrina A, Ross R, Harlan JM. Multiple receptors on human monocytes are involved in adhesion to cultured human endothelial cells. J Leukoc Biol. 1990 Nov;48(5):451–456. [PubMed]
  • Carlos T, Kovach N, Schwartz B, Rosa M, Newman B, Wayner E, Benjamin C, Osborn L, Lobb R, Harlan J. Human monocytes bind to two cytokine-induced adhesive ligands on cultured human endothelial cells: endothelial-leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1. Blood. 1991 May 15;77(10):2266–2271. [PubMed]
  • Waltz DA, Sailor LZ, Chapman HA. Cytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors. J Clin Invest. 1993 Apr;91(4):1541–1552. [PMC free article] [PubMed]
  • Waltz DA, Chapman HA. Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy. J Biol Chem. 1994 May 20;269(20):14746–14750. [PubMed]
  • Høyer-Hansen G, Rønne E, Solberg H, Behrendt N, Ploug M, Lund LR, Ellis V, Danø K. Urokinase plasminogen activator cleaves its cell surface receptor releasing the ligand-binding domain. J Biol Chem. 1992 Sep 5;267(25):18224–18229. [PubMed]
  • Fan ST, Edgington TS. Integrin regulation of leukocyte inflammatory functions. CD11b/CD18 enhancement of the tumor necrosis factor-alpha responses of monocytes. J Immunol. 1993 Apr 1;150(7):2972–2980. [PubMed]

Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...